Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
April 28 2022 - 7:41AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO
RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of April, 2022
Commission file number: 001-37891
AC IMMUNE SA
(Exact Name of Registrant as Specified in Its Charter)
EPFL Innovation Park
Building B
1015 Lausanne, Switzerland
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files
or will file annual reports under cover of Form 20-F or Form 40-F.
Indicate by check mark if the registrant is submitting
the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate by check mark if the registrant is submitting
the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
This
Report on Form 6-K (excluding Exhibit 99.3 herewith) is incorporated by reference into the Registrant's registration statements on
Form F-3 (File Nos. 333-227016, 333-249655 and 333-255576) and Form S-8 (File No. 333-233019).
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
AC IMMUNE SA |
|
|
|
|
|
By: |
/s/ Andrea Pfeifer |
|
|
Name: Andrea Pfeifer |
|
|
Title: Chief Executive Officer |
|
By: |
/s/ Joerg Hornstein |
|
|
Name: Joerg Hornstein |
|
|
Title: Chief Financial Officer |
Date: April
28, 2022
EXHIBIT INDEX
Exhibit
Number |
Description |
99.1 |
Interim Condensed Consolidated Financial Statements (Unaudited) (IFRS) as of and for the three months ended March 31, 2022 |
99.2 |
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
99.3 |
Press Release dated April 28, 2022 |
|
|
AC Immune (NASDAQ:ACIU)
Historical Stock Chart
From Aug 2024 to Sep 2024
AC Immune (NASDAQ:ACIU)
Historical Stock Chart
From Sep 2023 to Sep 2024